Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ONC | BEONE MEDICINES LTD | $346.75 | $19.31 | 1,695.28% | 6,935.00x | 103.94x | 7.68x | 9.30x | 6.70x | $529.27M | 1.39% | $4.13B | 37.48 | $36.28B | 114.07 | ||
| NVO | NOVO NORDISK A S | $58.91 | $149.23 | -60.52% | 16.38x | 2.56x | 5.38x | 10.00x | 0.17x | $9.34B | 3.57% | $26.18B | 5.89 | $272.42B | 10.98 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $366.86 | $36.86 | 895.40% | 1,183.42x | 52.72x | 15.02x | 207.22x | 3.85x | $221.36M | 0.46% | $233.89M | 1.78 | $50.19B | 330.36 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $39.56 | $17.39 | 127.52% | 80.73x | 22.99x | 4.94x | 5.60x | 1.00x | $101.73M | 3.44% | $535.38M | 7.17 | $2.83B | 52.88 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $9.17 | $16.47 | -44.33% | 19.10x | 16.12x | 6.08x | 3.88x | 0.25x | -$23.64M | -4.61% | $133.17M | 2.38 | $524.53M | 7.80 | ||
| CORT | CORCEPT THERAPEUTICS INC | $37.04 | $43.23 | -14.32% | 37.04x | 33.70x | 5.17x | 6.17x | 0.36x | $162.57M | 4.24% | $631.90M | 6.10 | $3.78B | 57.25 | ||
| VCEL | VERICEL CORP | $37.33 | $9.57 | 290.14% | 143.58x | 64.21x | 7.29x | 5.87x | 1.70x | $20.38M | 1.08% | $321.86M | 6.38 | $1.89B | 64.33 | ||
| ARGX | ARGENX SE | $799.33 | $363.14 | 120.12% | 31.94x | 27.08x | 25,784.84x | 6.80x | 1.34x | $467.72M | 0.96% | $7.17B | 117.50 | $46.38B | 57.17 | ||
| KRYS | KRYSTAL BIOTECH INC | $291.79 | $116.11 | 151.31% | 42.29x | 36.37x | 22.64x | 7.44x | 1.41x | $166.02M | 1.97% | $1.14B | 39.30 | $8.08B | 41.79 | ||
| TECH | BIO-TECHNE CORP | $68.40 | $16.33 | 318.77% | 136.80x | 33.83x | 8.74x | 5.42x | 1.87x | $224.06M | 2.11% | $1.97B | 12.65 | $10.91B | 49.38 | ||
| GMAB | GENMAB A | $35.34 | $128.43 | -72.48% | 15.08x | 2.02x | 6.37x | 3.95x | 0.11x | $1.19B | 5.26% | $5.75B | 8.96 | $21.07B | 10.53 | ||
| ABEO | ABEONA THERAPEUTICS INC | $5.19 | $19.16 | -72.92% | 3.26x | -96.29x | 741.43x | 1.64x | 0.19x | -$82.36M | -29.25% | $171.23M | 3.16 | $222.14M | 2.47 | ||
| ADMA | ADMA BIOLOGICS INC | $18.28 | $12.76 | 43.22% | 20.77x | 20.37x | 8.93x | 10.09x | 0.87x | $40.73M | 0.94% | $431.19M | 1.81 | $4.36B | 25.35 | ||
| XOMA | XOMA ROYALTY CORP | $29.36 | $15.89 | 84.77% | 36.25x | 93.38x | 7.57x | 4.13x | 0.96x | -$12.41M | -3.48% | $87.94M | 7.25 | $405.00M | 15.14 | ||
| AUPH | AURINIA PHARMACEUTICALS INC | $15.23 | $9.87 | 54.24% | 26.26x | 15.97x | 7.55x | 5.49x | 0.86x | $119.87M | 5.97% | $365.77M | 2.78 | $2.01B | 19.45 | ||
| VCYT | VERACYTE INC | $42.45 | $12.36 | 243.31% | 108.85x | 40.35x | 6.75x | 2.67x | 1.54x | $98.21M | 2.94% | $1.26B | 15.98 | $3.08B | 54.02 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $196.54 | $72.54 | 170.93% | 85.08x | 23.36x | 15.32x | 4.07x | 1.22x | $30.76M | 0.80% | $950.17M | 48.53 | $4.18B | 40.58 | ||
| CRMD | CORMEDIX INC | $7.09 | $17.88 | -60.35% | 3.12x | 2.81x | 2.51x | 1.49x | 0.54x | $74.42M | 13.82% | $374.13M | 4.93 | $659.04M | 5.87 | ||
| MNKD | MANNKIND CORP | $5.61 | $2.79 | 101.17% | 56.10x | 51.14x | 5.48x | -38.67x | 0.93x | $43.39M | 2.51% | -$44.55M | -0.15 | $1.95B | 26.71 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $6.31 | $4.33 | 45.56% | 23.37x | 20.97x | 4.04x | 7.13x | 0.83x | $21.15M | 4.20% | $70.68M | 0.89 | $442.34M | 19.49 | ||
| RPRX | ROYALTY PHARMA PLC | $40.21 | $47.37 | -15.11% | 22.85x | 7.77x | 7.39x | 2.41x | 0.40x | $2.11B | 12.16% | $9.62B | 22.28 | $31.22B | 29.90 | ||
| HALO | HALOZYME THERAPEUTICS INC | $72.96 | $81.03 | -9.96% | 14.92x | 8.80x | 6.88x | 17.03x | 0.51x | $602.40M | 7.04% | $503.92M | 4.30 | $9.67B | 11.44 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $449.53 | $191.03 | 135.32% | 31.41x | 21.98x | 9.80x | 6.59x | 1.52x | $3.34B | 2.90% | $17.32B | 67.76 | $110.95B | 23.80 | ||
| PLX | PROTALIX BIOTHERAPEUTICS INC | $2.06 | $3.58 | -42.51% | 29.43x | 11.65x | 2.64x | 3.13x | 0.24x | -$11.69M | -7.14% | $52.91M | 0.67 | $160.20M | 18.06 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $56.08 | $51.57 | 8.75% | 20.62x | 12.45x | 3.48x | 1.78x | 0.57x | $832.13M | 7.73% | $6.06B | 31.54 | $10.12B | 13.10 | ||
| APLS | APELLIS PHARMACEUTICALS INC | $20.33 | $6.70 | 203.52% | 58.09x | -18.31x | 2.53x | 6.41x | 1.60x | $78.64M | 3.06% | $401.17M | 3.17 | $2.57B | 27.49 | ||
| EXEL | EXELIXIS INC | $45.23 | $36.68 | 23.30% | 18.39x | 14.32x | 5.31x | 5.61x | 0.74x | $779.77M | 6.42% | $2.16B | 8.05 | $11.93B | 12.86 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $36.04 | $61.42 | -41.32% | 11.16x | 8.53x | 2.51x | 2.49x | 0.31x | $296.89M | 14.31% | $835.12M | 14.51 | $1.60B | 5.92 | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $23.17 | $22.71 | 2.02% | 12.94x | 11.88x | 4.91x | 3.09x | 0.69x | $234.54M | 8.26% | $920.25M | 7.51 | $2.16B | 6.67 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $754.14 | $413.92 | 82.20% | 17.36x | 16.37x | 5.48x | 2.56x | 1.70x | $4.22B | 5.40% | $30.96B | 298.82 | $79.46B | 13.91 | ||
| MDXG | MIMEDX GROUP INC | $5.69 | $5.08 | 12.12% | 20.32x | 22.77x | 2.14x | 3.53x | 0.60x | $66.82M | 7.93% | $238.95M | 1.61 | $718.83M | 10.39 | ||
| INVA | INNOVIVA INC | $19.74 | $19.45 | 1.49% | 10.44x | 9.03x | 3.51x | 1.46x | 0.85x | $196.54M | 14.42% | $1.01B | 14.63 | $1.26B | 5.85 | ||
| UTHR | UNITED THERAPEUTICS CORP | $475.73 | $252.20 | 88.63% | 16.70x | 15.99x | 6.66x | 3.11x | 1.99x | $1.12B | 5.38% | $6.59B | 150.46 | $19.14B | 10.80 | ||
| ACAD | ACADIA PHARMACEUTICALS INC | $26.86 | $12.40 | 116.67% | 17.11x | 33.36x | 4.33x | 4.95x | 2.95x | $197.81M | 4.36% | $917.27M | 5.43 | $4.32B | 15.01 | ||
| INCY | INCYTE CORP | $105.95 | $77.60 | 36.52% | 17.54x | 13.17x | 4.31x | 4.47x | 0.91x | $1.20B | 5.77% | $4.65B | 23.77 | $18.38B | 10.92 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.